Impact of Erector Spinae Plane Block on Chronic Postsurgical Pain in Breast Cancer Patients

Recruiting N/A Interventional Study
Breast Neoplasms Mastectomy Nerve Block Dexmedetomidine Pain, Postoperative Chronic Pain Prognosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Interventional
Purpose
Prevention
Participants needed
1,206 (estimated)
Sponsor
Peking University First Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Chronic postsurgical pain (CPSP) has an incidence of 46% in patients after breast cancer surgery, which seriously affects patients' physiological and psychological function, as well as quality of life. Acute pain is an independent risk factor for persistent pain after surgery. Erector spinae plane block (ESPB) provided excellent perioperative analgesia in patients undergoing breast surgery. Dexmed…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age of 18 years or over, but less than 85 years; 2. Scheduled to undergo mastectomy for primary unilateral breast cancer. Exclusion Criteria: 1. Previous breast cancer surgery with an incision of \>2 cm; 2. Chronic opioid dependence or long-term intake of analgesic medicine…
Contacts

Qiongfang Wu, M.D.

+8618310161109

wuqf91@163.com

CONTACT

Dong-Xin Wang, M.D., Ph.D.

+86 13910731903

wangdongxin@hotmail.com

CONTACT